Here are RSCI press releases for you to view. You can click the date and title to read the full press release.
The investigations for U.S. based venues for stem cell treatments will bolster RSCI’s already highly respected network of affiliated international stem cell treatment centers.
The treatment study using autologous (the patient’s own)adult stem cells will be conducted in the USA in April and will be available to the general public.
The new adult stem cell based method can help restore strength to damaged skeletal muscles in the elderly.
RSCI announces new Facebook and Twitter sites to provide the most up-to-date and accessible information about international stem cell treatments.
The petition asserts that “FDA control of a person’s own stem cells stifles medical progress and threatens the lives of those dying from incurable illnesses.”
ReGen Medical, PC will be among the highest profile of RSCI’s 14 international stem cell treatment centers.
FDA approved treatment with adult stem cells to be conducted in the United States in January is available to the general public.
Use of adult stem cells extracted from bone marrow may prove to retard progression of Multiple Sclerosis and other chronic neurological conditions.
Over 2000 successful clinical trials have proven the effectiveness of stem cell treatment for over 150 chronic conditions and diseases.
More people will now have access to the world's number one stem cell cardiologist, who, through Repair Stem Cell Institute, has dropped his rates more than 35% so that he can improve the lives of even more patients around the world.